Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings Profit Margin (Quarterly) : -42.05% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.05% |
| March 31, 2026 | -9.69% |
| December 31, 2025 | -126.4% |
| September 30, 2025 | -108.2% |
| June 30, 2025 | -147.3% |
| March 31, 2025 | -112.8% |
| December 31, 2024 | -82.43% |
| September 30, 2024 | -249.8% |
| June 30, 2024 | -26.53% |
| March 31, 2024 | -35.34% |
| December 31, 2023 | -148.3% |
| September 30, 2023 | -22.59% |
| June 30, 2023 | -17.33% |
| March 31, 2023 | -1.71% |
| Date | Value |
|---|---|
| December 31, 2022 | 42.71% |
| September 30, 2022 | 52.10% |
| June 30, 2022 | 64.57% |
| March 31, 2022 | 60.12% |
| December 31, 2021 | 55.64% |
| September 30, 2021 | 64.54% |
| June 30, 2021 | 61.76% |
| March 31, 2021 | 50.92% |
| December 31, 2020 | 14.71% |
| September 30, 2020 | 44.42% |
| June 30, 2020 | 3.07% |
| March 31, 2020 | 46.84% |
| December 31, 2019 | -15.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Repligen Corp. | 2.45% |
| Bio-Techne Corp. | 17.01% |
| BioLife Solutions, Inc. | -- |
| MindWalk Holdings Corp. | -158.7% |
| MaxCyte, Inc. | -122.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.07% |
| Return on Assets | -17.75% |
| Return on Invested Capital | -19.17% |
| Gross Profit Margin (Quarterly) | 40.14% |
| Operating Margin (Quarterly) | -28.97% |
| Return on Net Operating Assets | -25.99% |